Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00498082

Enrollment

Unknown

Registered

2007-07-09

Start date

2007-09-30

Completion date

2008-09-30

Last updated

2007-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Brief summary

EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome. The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Patients being considered for EsophyX treatment of GERD

Countries

Belgium

Contacts

Primary ContactHubert Piessevaux, MD, PhD

piessevaux@gaen.ucl.ac.be+ 32 2 764 28 34

Outcome results